Assembly Biosciences ASMB Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's operating lease liabilities (current)?
- Assembly Biosciences (ASMB) reported operating lease liabilities (current) of $590K in Q1 2026.
- How has Assembly Biosciences's operating lease liabilities (current) changed year-over-year?
- Assembly Biosciences's operating lease liabilities (current) increased by 11.5% year-over-year, from $529K to $590K.
- What is the long-term trend for Assembly Biosciences's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Assembly Biosciences's operating lease liabilities (current) has grown at a -30.1% compound annual growth rate (CAGR), from $3.4M to $569K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.